Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Edesa Biotech

4.43
-0.3300-6.93%
Post-market: 4.430.00000.00%19:59 EDT
Volume:156.24K
Turnover:706.24K
Market Cap:42.62M
PE:-2.56
High:4.95
Open:4.50
Low:4.17
Close:4.76
52wk High:20.32
52wk Low:0.7200
Shares:9.62M
Float Shares:5.60M
Volume Ratio:1.07
T/O Rate:2.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7319
EPS(LYR):-1.2658
ROE:-122.93%
ROA:-66.43%
PB:106.83
PE(LYR):-3.50

Loading ...

OverviewCompanyNewsFilings

Edesa Biotech announces $3.5M private placement

TIPRANKS
·
Jun 11

Edesa Biotech plans $3.5 million unregistered share sale in PIPE financing

Reuters
·
Jun 11

Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors

GlobeNewswire
·
Jun 11

Top Midday Stories: Lululemon Down After Fiscal Q1 Results; Amazon Engineers Criticize AI Spending; Hoffman to Exit Microsoft Board

MT Newswires Live
·
Jun 06

Edesa Biotech Reports Exploratory Kidney Outcomes Data in ARDS

TIPRANKS
·
Jun 05

Edesa Biotech reports exploratory data showing 32% lower 28-day mortality with paridiprubart in AKI patients with respiratory distress

Reuters
·
Jun 05

Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients With Acute Kidney Injury

THOMSON REUTERS
·
Jun 05

Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury

GlobeNewswire
·
Jun 05

Edesa Biotech Shareholders Approve Directors and Compensation Plans

TIPRANKS
·
May 30

Edesa Biotech shareholders approved 2019 equity plan amendment at annual meeting

Reuters
·
May 30

Edesa Biotech Inc trading halted, volatility trading pause

TIPRANKS
·
May 19

Edesa Biotech presents new paridiprubart acute kidney injury data at ERA Congress

Reuters
·
May 19

Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference

GlobeNewswire
·
May 19

Edesa Biotech Boosts CEO Equity-Based Compensation Structure

TIPRANKS
·
May 15

Edesa Biotech CEO Nijhawan takes 90% of base salary in fully vested RSUs

Reuters
·
May 15

Edesa Biotech Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Edesa Biotech Q2 FY26 net loss widens to $4.2 million

Reuters
·
May 15

Edesa Biotech Q2 EPS $(0.49) Misses $(0.26) Estimate

Benzinga Earnings
·
May 15

Edesa Biotech Q2 net loss widens as R&D spending rises

Reuters
·
May 15

Edesa Biotech Reports Fiscal 2Nd Quarter 2026 Results

THOMSON REUTERS
·
May 15
More